Advertisement

Topics

Teva Pharmaceutical Industries Limited Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

18:58 EDT 2 Oct 2018 | BioPortfolio Reports

Teva Pharmaceutical Industries Limited Strategy, SWOT and Corporate Finance Report


Summary


Teva Pharmaceutical Industries Limited Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Teva Pharmaceutical Industries Limited Teva or 'the company' is a generic pharmaceutical company. Teva is engaged in the development, production and marketing of generic, proprietary branded pharmaceuticals and active pharmaceutical ingredients. The company conducts its operations primarily in the Americas, Europe and Asia. It is headquartered in Petach Tikva, Israel.


Scope


Detailed information on Teva Pharmaceutical Industries Limited required for business and competitor intelligence needs

A study of the major internal and external factors affecting Teva Pharmaceutical Industries Limited in the form of a SWOT analysis

An indepth view of the business model of Teva Pharmaceutical Industries Limited including a breakdown and examination of key business segments

Intelligence on Teva Pharmaceutical Industries Limited's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Teva Pharmaceutical Industries Limited, such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Teva Pharmaceutical Industries Limited and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Teva Pharmaceutical Industries Limited as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Teva Pharmaceutical Industries Limited's business structure, strategy and prospects.

Original Article: Teva Pharmaceutical Industries Limited Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Teva Pharmaceutical Industries Limited Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...